Asthma Trials in Winston-Salem, United States
Conditions / Asthma / Winston-Salem, United States
Asthma has been the subject of sustained clinical investigation across multiple research sites.
90 total trials for this combination
Showing top 10 of 90 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02134028 | Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) | COMPLETED | PHASE3 |
| NCT01928771 | Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma | COMPLETED | PHASE3 |
| NCT02924688 | A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma | COMPLETED | PHASE3 |
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT03170271 | A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. | COMPLETED | PHASE3 |
| NCT06052267 | A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations | RECRUITING | PHASE3 |
| NCT05097287 | Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma | ACTIVE_NOT_RECRUITING | — |
| NCT00557180 | Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications | COMPLETED | — |
| NCT02258542 | A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA | COMPLETED | PHASE3 |
| NCT03769090 | A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma | COMPLETED | PHASE3 |